End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals-Reference-Cited by-同舟云学术

End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals

Published:2017-02-01 Issue:5 Volume:10 Page:429-430
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Shteyer Eyal¹,Dahari Harel²,Gafanovich Ina³,Dery Ilana³,Wolf Dana⁴,Cotler Scott J²,Lurie Yoav³

Affiliation:

1. Pediatric Liver Unit, Shaare Zedek Medical Center, 12 Beit, Jerusalem, 91031, Israel

2. The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Medical Center, Maywood, IL, USA

3. Liver Unit, Shaare Zedek Medical Center, Jerusalem, Israel

4. Clinical Virology Unit, Department of Clinical Microbiology & Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel

Publisher

SAGE Publications

Subject

Gastroenterology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756283X17694808

Reference5 articles.

1. Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

2. Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

3. Different Prevalence of HCV Resistance and HCV RNA Quantification Within Tumoral and Non Tumoral Liver Tissues in HCC/Transplanted Patients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ¿Qué sabemos acerca de la carga viral detectable al final del tratamiento de virus de hepatitis C con respuesta viral subsecuente?;Revista de Gastroenterología de México;2019-10

2. What do we know about detectable viremia at the end of hepatitis C virus treatment and the subsequent sustained virologic response?;Revista de Gastroenterología de México (English Edition);2019-10

3. Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography;PLOS ONE;2019-01-15

4. Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis;Liver International;2018-12-28

5. Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents;Immunology and Cell Biology;2018-06-05